NCT00740883View on ClinicalTrials.gov

"Extended Duration of Oral Anticoagulant Therapy After a First Episode of Idiopathic Pulmonary Embolism: a Randomized Controlled Trial. PADIS-PE Study."

PHASE3CompletedINTERVENTIONAL
Enrollment

374

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2016

Conditions
Pulmonary Embolism
Interventions
DRUG

warfarin

18 months of warfarin therapy, once daily

DRUG

placebo of warfarin

18 months of placebo of warfarin therapy, once daily

Trial Locations (1)

29609

Brest University Hospital, Brest

All Listed Sponsors
lead

University Hospital, Brest

OTHER

NCT00740883 - "Extended Duration of Oral Anticoagulant Therapy After a First Episode of Idiopathic Pulmonary Embolism: a Randomized Controlled Trial. PADIS-PE Study." | Biotech Hunter | Biotech Hunter